Reconciling sentinel node omission with CDK4/6 inhibitor eligibility in HR+/HER2- early breast cancer: a real-world cohort analysis

Saved in:
Bibliographic Details
Main Authors: Kandzi, Jannik Daniel (Author) , Englisch, Alexander (Author) , Böer, Bettina (Author) , Hahn, Markus (Author) , Wallwiener, Markus (Author) , Volmer, Léa (Author) , Brucker, Sara (Author) , Hartkopf, Andreas (Author) , Engler, Tobias (Author)
Format: Article (Journal)
Language:English
Published: 13 October 2025
In: Clinical breast cancer
Year: 2025, Pages: e1-e7
ISSN:1938-0666
DOI:10.1016/j.clbc.2025.10.003
Online Access:Resolving-System, kostenfrei: https://doi.org/10.1016/j.clbc.2025.10.003
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S1526820925002940
Get full text
Author Notes:Jannik Daniel Kandzi, Alexander Englisch, Bettina Boeer, Markus Hahn, Markus Wallwiener, Léa Volmer, Sara Brucker, Andreas Hartkopf, Tobias Engler
Description
Physical Description:Online Resource
ISSN:1938-0666
DOI:10.1016/j.clbc.2025.10.003